학술논문
A phase I dose escalation study of a humanized monoclonal antibody to EGFR (hR3) in patients with locally advanced squamous cell cancer of the head and neck (SCCHN) treated with radiotherapy
Document Type
Abstract
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 2002 54(2) Supplement:288-288
Subject
Language
ISSN
0360-3016